Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion description "[Previous semiquantitative studies of patients with chronic viral hepatitis showed that liver TGF beta 1 messenger RNA (mRNA) was increased, compared with normal controls and with patients with chronic hepatitis C virus (HCV) infection who responded favorably to interferon alfa (IFN alpha) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion evidence source_evidence_literature NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion SIO_000772 7843697 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion wasDerivedFrom befree-2016 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion wasGeneratedBy ECO_0000203 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.